Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density
NCT00238316Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2000
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Canadian Cancer Trials Group. Started Dec 2000; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00238316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238316.